This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Small-Cap Sector ETFs to Tap In Light of Q4 Earnings
by Sanghamitra Saha
Small-cap stocks have been staging a decent performance in recent times. These small-cap sector ETFs put up good numbers in the ongoing fourth-quarter earnings reporting season.
5 Small-Cap Sector ETFs Leading the Russell 2000 Rally
by Sweta Killa
We have presented five ETFs from different sectors that have easily crushed the Russell 2000 Index over the past month.
A Spread of Small-Cap ETFs Touching New Heights
by Sweta Killa
We have highlighted a number of small-cap ETFs that hit all-time highs in the last trading session and are among the popular choices.
Will These Small-Cap Sector ETFs Sizzle on Earnings Strength?
by Sanghamitra Saha
Small-cap stocks have been outperforming their bigger peers since late last year on vaccine and stimulus hopes.
Small-Cap Earnings Picture: 5 Sector ETF Stars
by Sanghamitra Saha
Total S&P 600 earnings for Q1 are expected to be down 41.5% from the same period last year on 4% lower revenues. However, these sectors show better earnings prospects.
Pick These US Small-Cap ETFs to Fight the Coronavirus Scare
by Sanghamitra Saha
Threatened by coronavirus? Here are a few U.S. small-cap ETFs to your rescue.
3 Sector ETFs to Follow Despite Dull Small-Cap Q2 Earnings
by Sanghamitra Saha
Albeit the Q2 earnings season reflects a bumpy ride for small-cap stocks, a few sectors offer better growth rates, putting the related ETFs under the spotlight.
Tense About Trade War? Follow Goldman With 5 ETF Strategies
by Sanghamitra Saha
Amid heightened US-China trade tensions, investors can land up on five ETF strategies and follow the suggestions of Goldman Sachs.
4 Small-Cap Sector ETFs Draw Attention Before Q4 Release
by Sanghamitra Saha
Prepare for Q4 earnings with these small-cap ETFs.
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, PowerShares Dynamic Semiconductors Fund, PowerShares S&P SmallCap Utilities Portfolio, PowerShares S&P SmallCap Energy Fund and Guggenheim S&P SmallCap 600 Pure V
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, PowerShares Dynamic Semiconductors Fund, PowerShares S&P SmallCap Utilities Portfolio, PowerShares S&P SmallCap Energy Fund and Guggenheim S&P SmallCap 600 Pure Value